Roivant Sciences (ROIV) Interest Coverage Ratio (2022 - 2024)
Roivant Sciences (ROIV) reported Interest Coverage Ratio of 7.63 for Q2 2024, up 75.4% on a YoY basis from 4.35 in Q3 2023, and down 101.41% quarter-over-quarter from 542.93 in Q4 2023.
Roivant Sciences (ROIV) Interest Coverage Ratio (2022 - 2024) Analysis & Trends
Roivant Sciences has reported Interest Coverage Ratio for 3 years, with the latest figure at 7.63 in Q2 2024.
- For the quarter ending Q2 2024, Interest Coverage Ratio rose 75.4% year-over-year to 7.63; the trailing twelve-month figure through Dec 2024 stood at 329.06 (up 113.27% YoY), and the FY2024 full-year result was 129.31, up 498.83% from the prior year.
- Interest Coverage Ratio for Q2 2024 stood at 7.63, down from 542.93 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 542.93 in Q4 2023, with the low at 108.08 in Q2 2022.
- Historically, Interest Coverage Ratio has averaged 42.09 across 3 years, with a median of 31.02 in 2023.
- The largest YoY upside for Interest Coverage Ratio was 1312.88% in 2023 against a maximum downside of 31.33% in 2023.
- Roivant Sciences' Interest Coverage Ratio stood at 44.76 in 2022, then jumped by 1312.88% to 542.93 in 2023, then plunged by 101.41% to 7.63 in 2024.
- The last three Interest Coverage Ratio figures came in at 7.63 (Q2 2024), 542.93 (Q4 2023), and 23.13 (Q3 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Roivant Sciences | 21.82 Bn | 22.59 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -7.63 |
| Dec 31, 2023 | 542.93 |
| Sep 30, 2023 | -23.13 |
| Jun 30, 2023 | -31.02 |
| Dec 31, 2022 | -44.76 |
| Sep 30, 2022 | -33.69 |
| Jun 30, 2022 | -108.08 |